Normas de Internet
FamousGadget Lda
FG is an IT base-tech and its main business core is to create disruptive software, such as SaaS, using investment partnerships as support and launch them after gain maturity as Spin-offs.
PAYXVIEW
LOCALTERMINAL
LOCALTERMINAL is a fast growing Smart Mobility Platform, aiming to achieve a sustainable and low impact form of transportation through a collaborative and eco-friendly travel platform, which facilitates the organization of collective transport as an alternative to the use of private cars.
To solve these inefficiencies LOCALTERMINAL offers:
– For travelers: Eco-efficient Social Trips from your town, with dynamic prices (more travelers mean lower prices) and a system of smart stops (pick-up points selected by travelers).
– For events and travel destinations: A Hub of Social Trips with multiple routes to facilitate the arrival of travelers from other locations in a sustainable way.
Doctor 4 Africa
Doctor 4 Africa
is a comprehensive Health Care Portal for all medical requirements in the 54 countries of Africa.
Sortlist
In a highly competitive and fast changing business world, competitors can emerge from anywhere. Agility is key for companies who want to lead the market, and there is no time to loose when looking for the best partner.
Have access to what your company needs when you need it:
– If you need an agency, find the best marketing partners that match your needs.
– If you are an agency, stop looking for clients. They will find you at Sortlist.
Mi Pequeña Fábrica
3D Design and Printing Solutions. Health 3D printing and education. 3D Design of customized products.
SyNoesis Therapeutics LTD
Our goal is to cure Parkinson’s disease (PD).
PD is incurable. 10 million people suffer from PD and rising. US expenditure on PD is US$ 14 billion.
We have developed a novel therapeutic that cures PD in mice. To take it to humans and enter clinical trials, we need to show that our therapeutic does not have side effects. This needs to be assessed by a toxicology study performed by an independent CRO. Provided that we meet this challenge, we have already been expressed funding interest by big pharmas for clinical trials. We seek investors to join in a de-risking 3-round funding strategy for a 2-stage milestone-based toxicology study (1st stage:250K-2nd stage:700k) and then for clinical trials (flexible, given the big pharmas interest).
Declarando
Our company was founded 3 years ago with one mission; automate the traditional taxation consultancy.
Fútbol Depredagol-5
